Change - Announcement of Appointment::APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER.

Issuer & Securities

Issuer/ Manager
NUTRYFARM INTERNATIONAL LIMITED
Securities
NUTRYFARM INTERNATIONAL LTD - BMG6700D1048 - AZT
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
27-Dec-2022 21:05:32
Status
New
Announcement Sub Title
APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER.
Announcement Reference
SG221227OTHR4ITR
Submitted By (Co./ Ind. Name)
CHAN YEE HONG
Designation
JUDICIAL MANAGER
Description (Please provide a detailed description of the event in the box below)
APPOINTMENT OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER.

Additional Details

Date Of Appointment
19/12/2022
Name Of Person
NIU LIMING
Age
47
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Judicial Manager has approved the appointment of Mr Niu as an Executive Director and Chief Executive Officer of the Company based on the Term Sheet entered.
Whether appointment is executive, and if so, the area of responsibility
Executive. Oversee the business of the group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Executive Officer.
Professional qualifications
Sep 2009 - Nov 2011: Business School of the University of Strathclyde - Master of Business Administration
Sep 1999 - Jun 2002: Chinese Academy of Sciences - Master of Science, President of Student Union of Institute of Earth Sciences
Sep 1993 - Jul 1997: Qingdao University - Bachelor of Science
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
Oct 2018 - Present: Corpbond Holdings Pte. Ltd. - Director
Dec 2017 - Present: Corpbond Investments Pte. Ltd. - Director
Dec 2012 - Present: Singapore Center for Innovation Collaboration and Technology Transfer Pte. Ltd. (formerly known as Broway Investment Pte. Ltd.) - Director and CEO
Jan 2016 - Dec 2017: Furong Investments Pte. Ltd. - Director and CEO
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
360,000 ordinary shares
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
AFG Combustion International Pte Ltd
BBT Biological Medicine Investment Pte Ltd
Coretex Industries Pte Ltd
Furong Investments Pte Ltd
KD Venture International Pte Ltd
KLS International Trade Group Pte Ltd
New Light Capital Pte Ltd
Ogas Energy Pte Ltd
Property International Group Pte Ltd
Present
Singapore Center for Innovation Collaboration and
Technology Transfer Pte. Ltd.
NEWID Pte Ltd
Free Cloud Pte Ltd
Xoriant Pte Ltd
Corpbond IV Ltd
Corpbond Holdings Pte. Ltd.
Corpbond Investments Pte. Ltd.
Asia-Europe International Trading Pte Ltd
Future Dance Pte Ltd
Bairong Holdings Pte Ltd
Ocean Bleu Capital Pte Ltd
Blue Ocean Family Office Pte Ltd
Glorious Cornerstone Investment Holding Pte Ltd
Glorious Wisdom Asset Management Pte Ltd
Best Union Management Pte Ltd
Kakura Dining Pte Ltd
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Mr Niu attended Directors Compliance Programme on 25 April 2017 by Singapore Institute of Directors.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
N.A.